Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             16 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Antitumor activity of HER1/EGFR tyrosine kinase inhibitor erlotinib, alone and in combination with CPT-11 (irinotecan) in human colorectal cancer xenograft models Chen, Jianping
2006
59 5 p. 651-659
artikel
2 Antitumour action of 5,6-dimethylxanthenone-4-acetic acid in rats bearing chemically induced primary mammary tumours Liu, Johnson J.
2006
59 5 p. 661-669
artikel
3 A phase I study of paclitaxel, cisplatin, and fluorouracil (TCF) for advanced gastric cancer Hara, Takuo
2006
59 5 p. 631-636
artikel
4 Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours? Bajetta, Emilio
2006
59 5 p. 637-642
artikel
5 Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study Santini, Daniele
2006
59 5 p. 613-620
artikel
6 Dihydrodiol dehydrogenase in drug resistance and sensitivity of human carcinomas Pan, Bih Fang
2006
59 5 p. 697-702
artikel
7 Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter Juergens, Rosalyn
2006
59 5 p. 621-629
artikel
8 Histological changes in bladders of patients submitted to ifosfamide chemotherapy even with mesna prophylaxis Lima, Marcos Venício Alves
2006
59 5 p. 643-650
artikel
9 In vitro anti-cancer activity and structure–activity relationships of natural products isolated from fruits of Panax ginseng Wang, Wei
2006
59 5 p. 589-601
artikel
10 Pharmacodynamic and toxicokinetic evaluation of the novel MEK inhibitor, PD0325901, in the rat following oral and intravenous administration Brown, Alan P.
2006
59 5 p. 671-679
artikel
11 Pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (AS1404), a novel vascular disrupting agent, in phase I clinical trial Jameson, M. B.
2006
59 5 p. 681-687
artikel
12 Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma Niioka, Takenori
2006
59 5 p. 575-580
artikel
13 Phase I dose-escalation study of a novel antitumor agent, SR271425, administered intravenously in split doses (d1–d2–d3) in patients with refractory solid tumors Campone, M.
2006
59 5 p. 689-695
artikel
14 Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer Beer, Tomasz M.
2006
59 5 p. 581-587
artikel
15 Role of nitric oxide on pathogenesis of 5-fluorouracil induced experimental oral mucositis in hamster Leitão, R. F. C.
2006
59 5 p. 603-612
artikel
16 Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models Chang, Yong S.
2006
59 5 p. 561-574
artikel
                             16 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland